MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0020733
Biolex Pharmaceutical Private Limited
Biolex Pharmaceutical Private Limited - pharma in Chandigarh, India. Directors, charges & compliance details.
Revenue · FY 2024
₹17.75 Lakh
▼ 29% YoY
Net profit · FY 2024
₹4,581
Net margin 0.3%
EBITDA · FY 2024
₹75,490
EBITDA margin 4.3%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹1.3 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Biolex Pharmaceutical Private Limited
Data last updated:
Biolex Pharmaceutical Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909CH2020PTC043192. Its GSTIN is 04AAJCB2451N1ZM (Chandigarh).
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors including Ravi Kumar Bhalla and Monika Bhalla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf No 320 New Motor Market And Commercial Complex, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.75 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹4,581 (net margin 0.3%) and EBITDA of ₹75,490 (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 824% over three years.
As per MCA filings, the company has open charges of ₹1.3 Cr on record.
Biolex Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0020733).
Company Details of Biolex Pharmaceutical Private Limited
CIN U51909CH2020PTC043192
Registration Number 043192
Incorporation Date 02 September 2020
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0020733
Recognitions & Rankings of Biolex Pharmaceutical
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressScf No 320 New Motor Market And Commercial Complex, Chandigarh, India – 160101
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Biolex Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Biolex Pharmaceutical Private Limited
The main business activity of Biolex Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Biolex Pharmaceutical Private Limited FY 2025 filings available
Biolex Pharmaceutical Private Limited reported revenue of ₹17.75 Lakh (down 29% YoY) for FY 2024.
Revenue · FY 2024
₹17.75 Lakh ▼ 29%
Net profit · FY 2024
₹4,581 margin 0.3%
EBITDA · FY 2024
₹75,490 margin 4.3%
Compounded Annual Growth Rate (CAGR) of Biolex Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▼ 29%
3 years · compounded
▲ 824%
EBITDA CAGR growth
1 year
▼ 84%
3 years · compounded
▲ 37%
Revenue fell 29% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 824%. EBITDA fell 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Biolex Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹75,490 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4,581 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Biolex Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biolex Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Biolex Pharmaceutical Private Limited
Biolex Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayush Kaushal | Additional Director | 30 Jan 2023 | 3 Years 8 Months | Current |
| Ravi Kumar Bhalla | Director | 02 Sep 2020 | 6 Years 1 Months | Current |
| Monika Bhalla | Director | 02 Sep 2020 | 6 Years 1 Months | Current |
Peer Comparison of Biolex Pharmaceutical Private Limited
Biolex Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vitabionics Healthcare Private Limited | ₹17.85 Lakh (FY 2025) | •••• | •••• | •••• | Kanpur, Uttar Pradesh, India | |
| Yma Ayurveda Private Limited | ₹17.83 Lakh (FY 2024) | •••• | •••• | 28.0% | •••• | Delhi, India |
| Resergene Biosciences Private Limited | ₹17.8 Lakh (FY 2024) | •••• | •••• | 148.0% | •••• | Bangalore, Karnataka, India |
| Hexcy Pharmaceutical Private Limited | ₹17.8 Lakh (FY 2019) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Eshram Pharmaceuticals Private Limited | ₹17.77 Lakh (FY 2021) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Biolex Pharmaceutical Private Limited this company | ₹17.75 Lakh (FY 2024) | •••• | •••• | -29.0% | •••• | Chandigarh, India |
| Bhumi Yug Health Care Private Limited | ₹17.74 Lakh (FY 2025) | •••• | •••• | 61.0% | •••• | Ujjain, Madhya Pradesh, India |
| Tatvamasmi Consulting Services Private Limited | ₹17.74 Lakh (FY 2025) | •••• | •••• | -44.0% | •••• | Hapur, Uttar Pradesh, India |
| Fencare Pharmaceuticals Private Limited | ₹17.71 Lakh (FY 2025) | •••• | •••• | -74.0% | •••• | Bangalore, Karnataka, India |
| TDPL Health Care (India) Limited | ₹17.61 Lakh (FY 2019) | •••• | •••• | -62.0% | •••• | Telangana, India |
| Telefirst Pharma Private Limited | ₹17.59 Lakh (FY 2024) | •••• | •••• | 194.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Biolex Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Biolex Pharmaceutical Private Limited
Open charges
₹1.3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2022 | Canara Bank | ₹1.3 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Biolex Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Biolex Pharmaceutical.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Biolex Pharmaceutical Private Limited
Biolex Pharmaceutical Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Ayush Kaushal was appointed as Additional Director on 30 Jan 2023.
AGM
Biolex Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biolex Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Ayush Kaushal was appointed as Additional Director.
Charges
A charge with Canara Bank amounted to Rs. 130.00 Lakh with Charge ID 100640427 was registered on 04 Nov 2022.
Ceased
Ayush Kaushal ceased to be Director.
Appointed
Monika Bhalla was appointed as Director.
Appointed
Ravi Kumar Bhalla was appointed as Director.
Incorporation
02 Sep 2020
Biolex Pharmaceutical Private Limited was registered on 02 Sep 2020 with Roc Chandigarh & aged 6 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Biolex Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biolex Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biolex Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Biolex Pharmaceutical Private Limited
Biolex Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAJCB2451N1ZM | Chandigarh | Active | 04 Mar 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biolex Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolex Pharmaceutical Private Limited
Biolex Pharmaceutical is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 September 2020 (6+ years old) and is registered under CIN U51909CH2020PTC043192.
Biolex Pharmaceutical reported revenue of ₹17.75 Lakh for FY 2024 (down 29% YoY).
Biolex Pharmaceutical has 3 current directors:
- Ayush Kaushal - Additional Director
- Ravi Kumar Bhalla - Director
- Monika Bhalla - Director
Biolex Pharmaceutical reported a net profit of ₹4,581 (net margin 0.3%) and EBITDA of ₹75,490 (EBITDA margin 4.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Biolex Pharmaceutical is 824% over three years. In the latest year (FY 2024) revenue fell 29%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Biolex Pharmaceutical is 04AAJCB2451N1ZM, registered in Chandigarh.
The CIN (Corporate Identification Number) of Biolex Pharmaceutical is U51909CH2020PTC043192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biolex Pharmaceutical was incorporated on 02 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Biolex Pharmaceutical by revenue are Vitabionics Healthcare Private Limited, Yma Ayurveda Private Limited, Resergene Biosciences Private Limited, Hexcy Pharmaceutical Private Limited, Eshram Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Ayush Kaushal was appointed as Additional Director on 30 Jan 2023. Ayush Kaushal ceased to be Director on 29 Oct 2022. Monika Bhalla was appointed as Director on 02 Sep 2020. Biolex Pharmaceutical has 4 board changes on record in total.
Yes, Biolex Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0020733).